Search for dissertations about: "Somatostatin analogs"
Showing result 1 - 5 of 11 swedish dissertations containing the words Somatostatin analogs.
-
1. Small Intestinal Neuroendocrine Tumor Analyses : Somatostatin Analog Effects and MicroRNA Profiling
Abstract : Small intestinal neuroendocrine tumors (SI-NETs) originate from serotonin-producing enterochromaffin (EC) cells in the intestinal mucosa. Somatostatin analogs (SSAs) are mainly used to control hormonal secretion and tumor growth. However, the molecular mechanisms leading to the control of SI-NETs are unknown. READ MORE
-
2. Current Medical Treatment of Endocrine Pancreatic Tumors and Future Aspects
Abstract : We treated 16 patients with somatostatin analogs combined with α-interferon and achieved a biochemical and/or radiological response in 56% (median duration 22 months). We consider this treatment a good alternative for patients who fail during chemotherapy or who do not want to/cannot receive cytotoxic drugs. READ MORE
-
3. Theranostics in Neuroendocrine Tumors : Somatostatin Receptor Imaging and Therapy
Abstract : Neuroendocrine tumors (NETs) are characterized by cellular overexpression of somatostatin receptors (SSTR), which allows for the use of radiolabeled somatostatin analogs (SSA) for both imaging and therapy. Because NETs often are diagnosed at a metastatic stage, curative surgery is not possible. READ MORE
-
4. Tailoring Radionuclide Therapy of Neuroendocrine Tumors - Bridging the Gaps
Abstract : Background and Aims: Radionuclide therapy is systemic, targeted radiotherapy. As such, we can apply the basic principles of radiobiology used in everyday practice in radiation oncology, as a means of tailoring the treatment to each patient and optimizing the balance between efficacy and toxicity. READ MORE
-
5. Small Intestinal Neuroendocrine Tumor : A Rare Malignancy with Favorable Outcome
Abstract : Small intestinal neuroendocrine tumor (SI-NET) is the most common small bowel tumor in Europe and USA, with an annual incidence of around 0.3-1.3/100000 persons. READ MORE